Pagaya Marks 100th ABS Deal with $650M Auto Securitization, Reinforcing Funding Access but Not Altering Margin Calculus

What happened

Pagaya closed RPM 2026-5, a $650 million auto asset-backed securitization, marking its 100th ABS deal since 2018 and bringing cumulative funding raised to over $44 billion. This milestone underscores Pagaya's continued access to capital markets and its ability to execute across asset classes, consistent with the recent string of upsized 2026 ABS transactions and new rating-agency support. However, the deal does not address the company's key sensitivity: FRLPC (fee-revenue-less-production-cost as a percent of network volume) fell to 4.6% in 1Q26 due to higher cost of capital, and management has tightened conversion ratios accordingly. While the 100th deal may bolster investor confidence and reinforce the funding narrative, it does not alter the core investment thesis centered on whether partner expansion can drive volume above $11.5B annualized while holding FRLPC at 4.6% or better. The stock remains a WAIT at $17.8, as the next 6+ months hinge more on margin durability and volume acceleration than on additional funding headlines.

Implication

The 100th ABS deal and $650M auto securitization reinforce that Pagaya can repeatedly access structured credit markets, which lowers the near-term liquidity risk and supports the current valuation multiple. Yet, the deal is incremental to existing funding strength and does not resolve the unit-economics pressure that caused FRLPC to dip to 4.6% in 1Q26. Investors should remain focused on 2Q26 results due in early November, where network volume within $2.875B-$3.075B and adjusted EBITDA of $100M-$115M will validate partner conversion. Any further disclosure of tightening conversion ratios or FRLPC below 4.0% would signal that funding availability is not translating into acceptable profitability. Conversely, if volume beats guidance with FRLPC stable or improving, the stock could re-rate toward $25, but until then the WAIT rating is appropriate.

Thesis delta

The closing of Pagaya's 100th ABS deal and the $650M auto securitization provide additional evidence of funding-market acceptance, slightly reducing downside risk to the funding-access pillar of the thesis. However, it does not shift the base-case probability or implied value because the core uncertainties—FRLPC sustainability and volume acceleration from new partners—remain unchanged. The thesis remains a WAIT with no change to the attractive entry of $15 or trim above $21.